The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
| Title |
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2012
|
| DOI | 10.1002/14651858.cd006504.pub2 |
| Pubmed ID | |
| Authors |
Michal Rolinski, Chris Fox, Ian Maidment, Rupert McShane |
| Abstract |
Previous Cochrane reviews have considered the use of cholinesterase inhibitors in both Parkinson's disease with dementia (PDD) and dementia with Lewy bodies (DLB). The clinical features of DLB and PDD have much in common and are distinguished primarily on the basis of whether or not parkinsonism precedes dementia by more than a year. Patients with both conditions have particularly severe deficits in cortical levels of the neurotransmitter acetylcholine. Therefore, blocking its breakdown using cholinesterase inhibitors may lead to clinical improvement. |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 18% |
| United States | 1 | 9% |
| United Kingdom | 1 | 9% |
| Germany | 1 | 9% |
| Unknown | 6 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 82% |
| Practitioners (doctors, other healthcare professionals) | 2 | 18% |
Mendeley readers
The data shown below were compiled from readership statistics for 592 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | <1% |
| Switzerland | 2 | <1% |
| United States | 2 | <1% |
| Netherlands | 1 | <1% |
| Czechia | 1 | <1% |
| France | 1 | <1% |
| Germany | 1 | <1% |
| Belgium | 1 | <1% |
| Canada | 1 | <1% |
| Other | 2 | <1% |
| Unknown | 576 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 85 | 14% |
| Researcher | 71 | 12% |
| Student > Ph. D. Student | 63 | 11% |
| Student > Master | 62 | 10% |
| Student > Postgraduate | 48 | 8% |
| Other | 134 | 23% |
| Unknown | 129 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 203 | 34% |
| Neuroscience | 50 | 8% |
| Psychology | 47 | 8% |
| Agricultural and Biological Sciences | 22 | 4% |
| Nursing and Health Professions | 22 | 4% |
| Other | 84 | 14% |
| Unknown | 164 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2023.
All research outputs
#4,252,211
of 25,887,951 outputs
Outputs from Cochrane database of systematic reviews
#6,614
of 13,154 outputs
Outputs of similar age
#26,003
of 169,872 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 186 outputs
Altmetric has tracked 25,887,951 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,154 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.5. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,872 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 186 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.